Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.760
-0.120 (-4.17%)
At close: Mar 27, 2026, 4:00 PM EDT
2.705
-0.055 (-2.00%)
After-hours: Mar 27, 2026, 7:42 PM EDT

Fortress Biotech Revenue

Fortress Biotech had revenue of $17.63M in the quarter ending September 30, 2025, with 20.52% growth. This brings the company's revenue in the last twelve months to $62.30M, down -0.32% year-over-year. In the year 2024, Fortress Biotech had annual revenue of $57.68M, down -31.76%.

Revenue (ttm)
$62.30M
Revenue Growth
-0.32%
P/S Ratio
1.37
Revenue / Employee
$616,861
Employees
101
Market Cap
85.66M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202457.68M-26.84M-31.76%
Dec 31, 202384.51M8.77M11.58%
Dec 31, 202275.74M6.95M10.11%
Dec 31, 202168.79M23.19M50.86%
Dec 31, 202045.60M8.97M24.49%
Dec 31, 201936.63M9.75M36.26%
Dec 31, 201826.88M9.64M55.88%
Dec 31, 201717.25M11.09M180.09%
Dec 31, 20166.16M5.29M613.44%
Dec 31, 2015863.00K--
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Gossamer Bio48.47M
Pyxis Oncology13.86M
Kazia Therapeutics1.27M
Seres Therapeutics789.00K
Spruce Biosciences697.00K
Revenue Rankings